Log in
Enquire now
‌

US Patent 11359203 Therapeutic inhibition of lactate dehydrogenase and agents therefor

Patent 11359203 was granted and assigned to Dicerna Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals
Current Assignee
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11359203
Date of Patent
June 14, 2022
Patent Application Number
16918239
Date Filed
July 1, 2020
Patent Citations
‌
US Patent 10738311 Therapeutic inhibition of lactate dehydrogenase and agents therefor
‌
US Patent 10011856 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
‌
US Patent 10351854 Therapeutic inhibition of lactate dehydrogenase and agents therefor
‌
US Patent 11053502 Therapeutic inhibition of lactate dehydrogenase and agents therefor
Patent Primary Examiner
‌
J. E. Angell
CPC Code
‌
C12N 15/1137
‌
C12N 2310/14
‌
C12N 15/113

This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11359203 Therapeutic inhibition of lactate dehydrogenase and agents therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.